Home › Funds › Cormorant Asset Management, LP › PHVS

Cormorant Asset Management, LP position in PHVS

PHARVARIS N V · Health Care

Cormorant Asset Management, LP reported holding 750,000 shares of PHVS (PHARVARIS N V) in its Q2 2026 13F filing — a position valued at US$25.9M, representing 1.33% of its reported portfolio and ranking #24 among its reported holdings. Cormorant Asset Management, LP has disclosed PHVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)750.00K sh
Reported value held$25.93M
Portfolio Weight1.33%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Cormorant Asset Management, LP's PHVS position evolved

Cormorant Asset Management, LP first disclosed a stake in PHVS in Q3 2023 at 1,361,460 shares (US$28.4M). The position peaked in Q4 2023 at 1,711,460 shares, worth US$48.0M. Across 12 filings, Cormorant Asset Management, LP increased the stake 1 time(s), trimmed it 6 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 750,000 shares valued at US$25.9M — a reduction of -250,000 shares quarter over quarter.. Notable position changes include a 26% increase in Q4 2023 (shares fell 33% over the following quarter), a 25% trim in Q2 2026 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.36M $28.41M New
Q4 2023 1.71M $48.01M Add
Q1 2024 1.71M $39.55M Hold
Q2 2024 1.47M $27.57M Reduce
Q3 2024 1.47M $27.16M Hold
Q4 2024 1.47M $28.11M Hold
Q1 2025 1.47M $23.02M Hold
Q2 2025 1.45M $25.60M Reduce
Q3 2025 1.36M $34.01M Reduce
Q4 2025 1.08M $30.05M Reduce
Q1 2026 1.00M $28.25M Reduce
Q2 2026 750.00K $25.93M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PHVS and 13F data

PHVS (PHARVARIS N V) is a Health Care company. 49 other funds we track also report a position in PHVS — the largest reported positions include GENERAL ATLANTIC, L.P. (US$226.5M), Foresite Capital Management IV, LLC (US$165.2M), venBio Partners LLC (US$160.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PHVS

All PHVS fund holders →

FAQ

How long has Cormorant Asset Management, LP held PHVS?

Cormorant Asset Management, LP has disclosed PHVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Cormorant Asset Management, LP's current position in PHVS?

As of Q2 2026, Cormorant Asset Management, LP holds 750.00K shares of PHVS (PHARVARIS N V), valued at $25.93M, representing 1.33% of its reported portfolio and ranking #24.

Has Cormorant Asset Management, LP been buying or selling PHVS?

In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP reduced its position in PHVS. The position peaked in Q4 2023 at 1.71M shares.

Which other funds hold PHVS?

Other major institutional holders of PHVS include GENERAL ATLANTIC, L.P., Foresite Capital Management IV, LLC, venBio Partners LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.